Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 14.29 % |
3 Month Return | + 19.41 % |
1 Year Return | + 90.2 % |
Market Stats | |
Previous Close | ₹1,290.50 |
Open | ₹1,300.00 |
Volume | 1,548.00 |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹580.22Cr |
P/E Ratio | 0 |
PEG Ratio | 0 |
Market Cap | ₹580.22 Cr |
P/B Ratio | 2.1 |
EPS | 0 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | 19.44 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹580.22 Cr | 44.82% | 0.51 | NA | NA | |
NA | ₹435.76 Cr | 272.24% | 0.54 | ₹28 Cr | ₹601 Cr | |
NA | ₹15.41 Cr | 278.33% | 0.50 | NA | NA | |
BUY | ₹23,100.09 Cr | 3.59% | 0.52 | NA | NA | |
NA | ₹706.49 Cr | -0.07% | 0.57 | ₹9 Cr | ₹179 Cr |
Organisation | Jenburkt Pharmaceuticals Ltd |
Headquarters | |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 3 months, Jenburkt Pharma stock has moved up by 20.9%
Best in 1 Year
In the last 1 year, Jenburkt Pharma has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Best in 3 Years
In the last 3 years, Jenburkt Pharma has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Promoter Holding Unchanged
Promoters holdings remained unchanged at 46.71% of holdings in Sep 2024 quarter
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 53.29% of holdings in Sep 2024 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 46.71% | 0.00 | |
Foreign Institutions | 0% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 53.29% | 0.00 | |
Others | 0% | 0.00 |
Jenburkt Pharmaceuticals Ltd’s net profit jumped 31.15% since last year same period to ₹9.60Cr in the Q2 2024-2025. On a quarterly growth basis, Jenburkt Pharmaceuticals Ltd has generated 29.38% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, Jenburkt Pharmaceuticals Ltd has declared dividend of ₹15.30 - translating a dividend yield of 1.23%.
Read More about DividendsBearish
Neutral
Bullish
Jenburkt Pharmaceuticals Ltd is currently in a Bullish trading position according to technical analysis indicators.
Jenburkt Pharmaceuticals Ltd (524731) share price today is ₹1242.4
Jenburkt Pharmaceuticals Ltd is not listed on NSE
Jenburkt Pharmaceuticals Ltd is listed on BSE
Today’s traded volume of Jenburkt Pharmaceuticals Ltd(524731) is 1,548.00.
Today’s market capitalisation of Jenburkt Pharmaceuticals Ltd(524731) is ₹580.22Cr.
Jenburkt Pharmaceuticals Ltd(524731 | Price |
---|---|
52 Week High | ₹1375 |
52 Week Low | ₹658.6 |
Jenburkt Pharmaceuticals Ltd(524731) share price is ₹1242.4. It is down -9.64% from its 52 Week High price of ₹1375
Jenburkt Pharmaceuticals Ltd(524731) share price is ₹1242.4. It is up 88.64% from its 52 Week Low price of ₹658.6
Jenburkt Pharmaceuticals Ltd(524731 | Returns |
---|---|
1 Day Returns | -48.1% |
1 Month Returns | 14.29% |
3 Month Returns | 19.41% |
1 Year Returns | 90.2% |